Roche gets USFDA nod for Columvi to treat relapsed or refractory diffuse large B cell lymphoma Ruchika Sharma18 Jun 2023 2:42 PM ISTColumvi is a CD20xCD3 T-cell-engaging bispecific antibody designed to target CD3 on the surface of T-cells and CD20 on the surface of B-cells.
Takeda, HUTCHMED gets EMA validation for marketing authorization application for Fruquintinib for Metastatic Colorectal Cancer Ruchika Sharma18 Jun 2023 12:15 PM ISTOsaka: Takeda and HUTCHMED (China) Limited have announced that the European Medicines Agency (EMA) has validated and accepted for regulatory...
Prometheus Biosciences now wholly-owned subsidiary of Merck Ruchika Sharma18 Jun 2023 10:00 AM ISTUnder the terms of the acquisition agreement, Merck, through a subsidiary, has acquired all outstanding shares of Prometheus for USD 200.00 per share...
Submit safety and efficacy data: CDSCO panel Tells Zydus on Anticancer Drug Relugolix Dr. Divya Colin18 Jun 2023 10:00 AM ISTNew Delhi: In response to the drug major Zydus's proposal for the manufacture and marketing of the drug Relugolix 120 mg tablets, the Subject Expert...
USFDA issues EIR for Torrent Pharma Bileshwarpura facility Ruchika Sharma17 Jun 2023 4:17 PM ISTAhmedabad: Torrent Pharma has recently announced that the US Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR)...
CDPQ divests 0.89 percent stake in Piramal Pharma for Rs 100 crore Ruchika Sharma17 Jun 2023 1:30 PM ISTVanguard Group acquired more than 62 lakh shares of Piramal Pharma at an average price of Rs 94.71 per share, while other buyer(s) identity is not...
USFDA inspection: Dr Reddy's Labs gets zero obervations for Bollaram facility, EIR for Srikakulam facility Ruchika Sharma17 Jun 2023 12:10 PM ISTHyderabad: Dr Reddy's Labs has announced that the United States Food & Drug Administration (USFDA) has completed a GMP inspection at the...
Coherus resolves part of dispute with AbbVie over Humira biosimilar Ruchika Sharma17 Jun 2023 11:00 AM ISTCoherus BioSciences said on Thursday it had agreed to retract a restraining order against AbbVie as the two fight over the terms of launching a...
USFDA extends review period of GSK Momelotinib by three months Ruchika Sharma17 Jun 2023 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has extended the review period of the new drug application (NDA) for...
Fortis Healthcare fund diversion case: SEBI issues demand notices to 4 entities Ruchika Sharma16 Jun 2023 4:06 PM ISTIn four fresh notices dated June 9, SEBI directed them to pay Rs 4.56 crore, which includes interest and recovery cost, within 15 days.
UP Govt preparing draft of Pharmaceutical Industry Policy 2023 Ruchika Sharma16 Jun 2023 2:30 PM ISTAccording to the policy, the Yogi government would provide a 50 per cent interest for a maximum of 7 years on the loan received from a bank for the...
Natco Pharma Vizag facility gets EIR from USFDA Ruchika Sharma16 Jun 2023 1:30 PM ISTHyderabad: Natco Pharma Limited has announced the successful closure of inspection and received Establishment Inspection Report (EIR) from the...
